LOW-VOLUME · SEX-BALANCED
vericiguat Side Effects
vericiguat (also sold as Verquvo) is a LOW-VOLUME FAERS extract #492 of 524 by FAERS report count. Still opens on SEX-BALANCED: 34% of sex-coded reports are female (290 F / 567 M).
Data updated 2026-05-15
- 905
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
vericiguat reporting skew - 34% of sex-coded reports are female (290 F / 567 M). Volume band LOW-VOLUME #492 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for vericiguat (Verquvo) (905 reports #492 of 524 by FAERS report count). 34% of sex-coded reports are female (290 F / 567 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2017–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
HYPOTENSION leads 106 of 905 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (181 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (135 reports, 14.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 89 |
| CARDIAC FAILURE | 19 |
| ILL-DEFINED DISORDER | 8 |
| CARDIAC ARREST | 7 |
| ADVERSE EVENT | 6 |
| CARDIAC DISORDER | 5 |
| PNEUMONIA | 5 |
| ILLNESS | 4 |
| TREATMENT NONCOMPLIANCE | 4 |
| ATRIAL FIBRILLATION | 3 |
| BLOOD PRESSURE DECREASED | 3 |
| BRAIN NATRIURETIC PEPTIDE INCREASED | 3 |
| CHRONIC KIDNEY DISEASE | 3 |
| EJECTION FRACTION DECREASED | 3 |
| HOSPICE CARE | 3 |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 3 |
| MALAISE | 3 |
| MYOCARDIAL INFARCTION | 3 |
| NAUSEA | 3 |
| RENAL FAILURE | 3 |
Reactions in Hospitalization Reports
Hospitalization mid-share (215, 23.8%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| CARDIAC FAILURE | 36 |
| HYPOTENSION | 24 |
| HOSPITALISATION | 19 |
| ANAEMIA | 16 |
| DEATH | 16 |
| ADVERSE EVENT | 13 |
| DYSPNOEA | 12 |
| ASTHENIA | 9 |
| DIZZINESS | 8 |
| OEDEMA PERIPHERAL | 8 |
| ATRIAL FIBRILLATION | 7 |
| BLOOD PRESSURE DECREASED | 7 |
| PNEUMONIA | 7 |
| ACUTE KIDNEY INJURY | 6 |
| CARDIAC FAILURE CHRONIC | 6 |
| GASTROINTESTINAL HAEMORRHAGE | 6 |
| MALAISE | 6 |
| RENAL IMPAIRMENT | 6 |
| CARDIAC DISORDER | 5 |
| DYSPNOEA EXERTIONAL | 5 |
How to read vericiguat FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-MID)
FAERS holds 905 voluntary reports linked to vericiguat (Verquvo), 2017-2025. Death is listed on 135 (14.9%). Hospitalization appears on 215 (23.8%). Top co-reported indication: Cardiac Failure.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with vericiguat
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 911 FAERS cases (Δ 6 heavier vs vericiguat); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 896 FAERS cases (Δ 9 lighter vs vericiguat); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 923 FAERS cases (Δ 18 heavier vs vericiguat); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 863 FAERS cases (Δ 42 lighter vs vericiguat); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 47.2 pp vs vericiguat's DEATH-HEAVY): CASELOAD · HOSP-MID.
vericiguat stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.